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a b s t r a c t
Transcriptional enhancers integrate information derived from transcription factor binding to control
gene expression. One key question concerns the extent of trans- and cis-regulatory variation in how co-
expressed genes are controlled. The Drosophila CNS midline cells constitute a group of neurons and glia
in which expression changes can be readily characterized during speciﬁcation and differentiation. Using
a transgenic approach, we compare the cis-regulation of multiple genes expressed in the Drosophila CNS
midline primordium cells, and show that while the expression patterns may appear alike, the target
genes are not equivalent in how these common expression patterns are achieved. Some genes utilize a
single enhancer that promotes expression in all midline cells, while others utilize multiple enhancers
with distinct spatial, temporal, and quantitative contributions. Two regulators, Single-minded and Notch,
play key roles in controlling early midline gene expression. While Single-minded is expected to control
expression of most, if not all, midline primordium-expressed genes, the role of Notch in directly
controlling midline transcription is unknown. Midline primordium expression of the rhomboid gene is
dependent on cell signaling by the Notch signaling pathway. Mutational analysis of a rhomboid enhancer
reveals at least 5 distinct types of functional cis-control elements, including a binding site for the Notch
effector, Suppressor of Hairless. The results suggest a model in which Notch/Suppressor of Hairless levels
are insufﬁcient to activate rhomboid expression by itself, but does so in conjunction with additional
factors, some of which, including Single-minded, provide midline speciﬁcity to Notch activation.
Similarly, a midline glial enhancer from the argos gene, which is dependent on EGF/Spitz signaling, is
directly regulated by contributions from both Pointed, the EGF transcriptional effector, and Single-
minded. In contrast, midline primordium expression of other genes shows a strong dependence on
Single-minded and varying combinations of additional transcription factors. Thus, Single-minded
directly regulates midline primordium-expressed genes, but in some cases plays a primary role in
directing target gene midline expression, and in others provides midline speciﬁcity to cell signaling
inputs.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Genomic enhancers control transcription by integrating the
contributions of multiple DNA-binding transcription factors, lead-
ing to modiﬁcation of chromatin and recruiting core transcrip-
tional machinery to promoter elements (Ong and Corces, 2011;
Spitz and Furlong, 2012). One of the most interesting aspects of
enhancer function concerns how coordinately expressed eukaryo-
tic genes are regulated, an issue that dates back to the ground-
breaking contributions by Britten and Davidson (1971). Does the
same group of transcription factors control transcription of each
co-expressed gene in the same manner, utilizing a highly-
conserved binding site code, or is the situation more variable
(Yáñez-Cuna et al., 2013)? In the case of Ciona, genes co-expressed
in muscle utilize a common set of transcription factors with a
variable combination of binding sites to control transcription
(Brown et al., 2007). Similarly, in the Drosophila embryo, a shared
set of transcription factors control gene expression in the devel-
oping mesoderm, yet different co-expressed genes can utilize
different transcription factors and binding site architectures,
arguing against a strict mesoderm code (Zinzen et al., 2009). Still,
the co-expression of genes may be idiosyncratic and variable
depending on the regulatory proteins involved and how during
evolution their respective target genes came to be expressed in the
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same cell type. Since evolution is dependent to a substantial
degree on the control of gene expression (Carroll et al., 2001;
Davidson., 2006), it is important to study a broad sampling of the
gene regulatory landscape.
Study of the Drosophila CNS midline cells has a number of
advantages for understanding enhancer function and gene regula-
tion during development. Midline cell expression of a gene is
particularly easy to identify due to the characteristic midline stripe
of embryonic expression. The development of the midline cells is
well understood, with many of the key regulatory proteins
identiﬁed (Thomas et al., 1988; Watson et al., 2011; Watson and
Crews, 2012; Wheeler et al., 2008). In particular, the Drosophila
single-minded (sim) gene, which encodes a bHLH-PAS transcription
factor, controls early development of the CNS midline cells
(Nambu et al., 1991) by acting as a transcriptional activator that
promotes the midline transcriptional program (Nambu et al., 1990)
and indirectly represses the lateral CNS program (Estes et al.,
2001). The Sim protein forms a heterodimer with the Tango (Tgo)
bHLH-PAS protein to bind the DNA sequence ACGTG, called the
CNS Midline Element (CME) (Sonnenfeld et al., 1997; Wharton et
al., 1994). The CME is present and functional in nearly all midline
enhancers studied to date (Apitz et al., 2005; Estes et al., 2008;
Hong et al., 2013; Long et al., 2014; Pearson et al., 2012; Wharton
et al., 1994), consistent with the possibility that Sim:Tgo directly
activates most midline-speciﬁc gene expression.
Recent studies have promoted a model in which sim initially
commits ectodermal cells to a single midline neuronal precursor
fate followed by a series of signaling events that further diversify
midline cell fates (Watson and Crews, 2012). During midline cell
differentiation, sim continues to control transcription in midline
glia (MG) (Estes et al., 2008; Wharton et al., 1994) and may
interact with the Notch signaling pathway, another important
regulator of MG transcription and development (Wheeler et al.,
2008). At the midline primordium stage, Notch signaling through
its transcriptional effector, Suppressor of Hairless (Su(H)), controls
MG and midline neuronal cell fate and transcription. This raises a
number of issues. Does Notch signaling mainly inﬂuence tran-
scription in midline cells by maintaining sim expression? Alter-
natively, does Notch signaling, via Su(H), directly regulate many
midline-expressed genes, and does it control transcription in
conjunction with Sim and other midline-expressed transcription
factors? How do these Notch-dependent midline genes restrict
expression to the midline, given the number of tissues utilizing
Notch signaling in the embryo?
In this paper, we use transgenic approaches to identify and
analyze enhancers that drive midline expression from a variety of
genes that all show similar expression in midline primordium
cells. These experiments reveal considerable mechanistic diversity
in controlling their midline primordium expression. In one mode,
including the genes Ectoderm-expressed 3 (Ect3), midline fasciclin
(mfas), Sema-1b, and Toll (Tl), there is a single enhancer that drives
midline primordium expression. In another mode (rhomboid (rho),
sim autoregulation), midline primordium expression is a sum of at
least two distinct enhancers. In all tested cases, Sim binding
contributes to midline expression. However, mutation of canonical
Sim:Tgo binding sites (CMEs) results in different outcomes
depending on the enhancer. Whereas midline primordium expres-
sion is absent when CMEs are mutated in the Sema-1b, sim
autoregulatory, and Tl enhancers, the effect on two enhancers of
genes strongly inﬂuenced by cell–cell signaling (rho, argos) is
relatively minor. However, mutation of a rho Su(H) binding site
results in a severe decrease of expression. Additional cis-control
elements were identiﬁed in the rho enhancer, suggesting a model
in which rho midline primordium expression is dependent on
Notch/Su(H) signaling, but Su(H) activation is insufﬁcient to
activate expression by itself. The CMEs and additional functional
cis-control elements, including Sox protein motifs, provide midline
speciﬁcity in conjunction with Su(H) activation and drive rho
expression in the midline cells. The argos gene, controlled by
EGF/Spitz (Spi) signaling (Schweitzer et al., 1995), is regulated by
Pointed, the transcriptional effector of Spi signaling, with a
contribution by Sim, again suggesting that a “Signal plus Sim”
code is common for midline-expressed genes controlled by cell
signaling. This resembles the “Notch plus Proneural” code pro-
posed for Notch signaling in lateral inhibition of neural fates
(Castro et al., 2005). In summary, there is considerable diversity
in the activity of enhancers controlling a common pattern of
midline primordium gene expression, complicating attempts to
derive a common “cis-regulatory code” underlying this simple
expression pattern.
Materials and methods
Drosophila strains and genetics
Drosophila strains used include: sim-3.7-Gal4 (Xiao et al., 1996),
UAS-tau-GFP (Wheeler et al., 2006), sim-3.7-Gal4 UAS-tau-GFP
(Wheeler et al., 2006), sim-1.0-Gal4 (Freer et al., 2011), UAS-
mCD8-GFP(LL6) (Lee and Luo, 1999), simH9 (Hilliker et al., 1980),
UAS-sim (Xiao et al., 1996), prd-Gal4 (BL 1947), Dl3 (Uemura et al.,
1989), UAS-Su(H).VP16 (Kidd et al., 1998), 12xSu(H)bs-lacZ (Go et
al., 1998), rho-1.0-GFP (rho PE-A-GFP; kindly provided by J. Posak-
ony), UAS-aop.Act (BL 5789), UAS-pnt.P1 (BL 869), TM3-ftz-lacZ (BL
3218), and nanos-phiC31; attP2 (68A1-B2) (Groth et al., 2004).
Sequence analysis and bioinformatics
Enhancer alignments and identiﬁcation of motifs were per-
formed as described previously (Pearson et al., 2012). Locus
schematics were modiﬁed from GenePalette (Rebeiz and
Posakony, 2004), and enhancer schematics were modiﬁed from
Twine (Pearson and Crews, 2013). BDTNP DNase hypersensitivity
(Thomas et al., 2011), blastoderm transcription factor ChIP–chip
data (Li et al., 2008), and Zelda ChIP-Seq data (Harrison et al.,
2011) were accessed on the UCSC Genome Browser (genome.ucsc.
edu; Meyer et al., 2013).
DNA constructs
All enhancer fragments were PCR-ampliﬁed and cloned into
pENTR or pCR8 (Life Technologies), then were cloned into pMint-
gate (Jiang et al., 2010) or pBPGw-UCP (Wheeler et al., 2012) using
Gateway LR Clonase II (Life Technologies). Site mutations were
introduced by PCR-based site-directed mutagenesis and PCR-
sewing. PCR Primers were synthesized by IDT or Operon, and are
listed in Supplementary Table 1.
in situ hybridization and immunostaining
Embryo collection, in situ hybridization, immunostaining, and
confocal imaging were performed as previously described
(Kearney et al., 2004; Wheeler et al., 2006, 2008). Digoxigenin-
or biotin-labeled antisense RNA probes for GFP, Gal4, and lacZ
were PCR-ampliﬁed from plasmids and cloned into pCR2.1. Probes
for Drosophila genes were generated from the following Drosophila
Gene Collection clones: Tl (GH03720), mfas (GH11519), Ect3
(HL01076), Sema-1b (GH03186), and rho (LD06131). Primary anti-
bodies used were rabbit anti-GFP (Abcam), mouse anti-tau
(Sigma), mouse anti-En (4D9) (Patel et al., 1989), and guinea pig
anti-Sim (Pearson et al., 2012). Segments T3-A2 were analyzed for
all sagittal single segment images.
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Imaging and image analysis
Imaging was performed on a Zeiss Pascal confocal microscope.
Brightness and minimum signal threshold of each confocal chan-
nel were adjusted for clarity and to remove non-speciﬁc noise
using ImageJ (Abramoff et al., 2004), except in cases where images
were taken with identical confocal settings for comparison pur-
poses. Image stacks were rotated along the X- or Y-axis using the
TransformJ plugin for ImageJ (http://www.imagescience.org/mei
jering/software/transformj/) to generate sagittal views of midline
segments. Original confocal stacks are available on request.
Results
Common patterns of midline primordium gene expression
During embryogenesis, the embryonic CNS midline cells give
rise to 22 neurons and glia per segment that play important
roles in neurodevelopmental and neurobiological processes
(Wheeler et al., 2006). The midline glia (MG) consist of two
subpopulations: anterior midline glia (AMG) and posterior midline
glia (PMG) (Wheeler et al., 2006). The midline neurons arise from
6 precursors: Midline Precursors 1,3,4,5,6 (MP1,3,4,5,6) and the
median neuroblast (MNB) stem cell (Fig. 1; Wheeler et al., 2006).
At the mesectodermal (stages 5–8) and early midline primordium
stages (stages 9–10), the midline cells appear relatively uniform. In
the late midline primordium (stage 11), midline cells begin to
divide, migrate, and develop into midline neurons and MG. In this
paper, we analyze 5 genes that are expressed in a similar manner
in the midline primordium (Fig. 2D–S) to address questions
regarding their similarities and dissimilarities in midline gene
regulation.
The sim gene is prominently expressed in all midline cells at
the mesectodermal (stages 5–8) and midline primordium (stages
9–11) stages (Figs. 1, 2A–C, S). At stage 10, all ﬁve genes analyzed
(Ect3, mfas, rho, Sema-1b, Tl) are co-expressed in all midline
primordium cells in thoracic and abdominal segments (Fig. 2D,
G, J, M, P), although Ect3 and mfas expression is reduced in the
head segments compared to the other genes. After stage 10, their
patterns become more complex. At early stage 11 (s11(e)), each
gene is expressed in MPs and MG (Fig. 2E, H, K, N, Q, T). While
delaminating MPs sometimes show a burst of enhanced expres-
sion (for example, rho; white arrowhead, Fig. 2H), expression is
generally reduced upon MP delamination and division (Fig. 2E, K,
N, Q, T; red bracket). By late stage 11 (s11(l)), midline expression is
clearly discontinuous: present in AMG, often PMG, but generally
absent in delaminating MPs and their neuronal progeny (Fig. 2F, I,
L, O, R, T). This pattern is different than that of Sim protein, since at
stage 11, Sim protein is abundant in all midline primordium cells,
including divided MPs (Fig. 2B, C; red bracket). Consequently, the
discontinuous nature of the 5-gene expression pattern is not due
solely to sim function. However, the modulation of expression
resembles the positive inﬂuence of Notch as indicated by expres-
sion of Notch signaling reporter transgenes (Wheeler et al., 2008).
These reporters also show strong activation in AMG, PMG, and
MNB, but are weakly activated in midline MPs and their neuronal
progeny. These data indicate that the 5 genes analyzed are
expressed in the midline primordium in a similar manner: ﬁrst
in all midline cells and then in a common subset. Based solely on
common expression patterns, sim may directly control expression
of these genes in all midline primordium cells at stages 9–11(e)
(Fig. 2T), but this expression is modulated during stage 11 by other
inputs, including Notch signaling. Although not well appreciated,
sim expression is also modulated, changing from all midline cells
after stage 11 to a Notch-dependent subset (AMG, PMG, H-cell sib,
iVUMs, and MNB progeny) in stage 12 and later embryos (Wheeler
et al., 2008).
Both separable and composite enhancers control midline primordium
expression
Transgenic analysis of putative cis-regulatory regions was
utilized to determine how midline primordium expression is
controlled in vivo. This approach can address whether a single
enhancer integrates transcription factor inputs to drive midline
primordium expression or whether expression is dependent on
multiple, separable enhancer elements each capable of driving
different aspects of midline expression.
Sim
Previous data for sim indicated that multiple enhancers control
midline primordium expression (Supplementary Fig. S1A; Kvon et
al., 2012; Manning et al., 2012; Markstein et al., 2004). An
enhancer responsive to dorsal–ventral patterning transcription
factors Dorsal, Snail (Sna), Twist (Twi), and Notch signaling initiate
midline expression in the mesectoderm from the sim early
promoter (PE) (Fig. 3A) (Cowden and Levine, 2002; Kasai et al.,
Fig. 1. Overview of early CNS midline cell development. Single segments are
depicted at successive stages of development. (A) Horizontal view of stages 5–6
midline cells (referred to as mesectoderm at these stages). Two single cell-wide
stripes of 4 cells each converge at the embryonic midline (dotted line) during
gastrulation (stages 6–7). (B) After gastrulation, the mesectodermal cells undergo a
synchronous cell division to give rise to 16 cells/segment at stages 8–10 (referred to
as the midline primordium) and intercalate. Sagittal view is depicted. (C) At early
stage 11 (11(e)), MP4 has delaminated and divided into mVUM4 (m4) and iVUM4
(i4), while MP1, MP3, and MP5 have delaminated but not yet divided into their
neuronal progeny. The remaining midline cells (gray) are a mixture of the not-yet-
delaminated MP6, newly formed MG, and the MNB. (D) By late stage 11 (11(l)),
MP1,3–6 have delaminated and divided. MP1 has divided symmetrically into the
2 MP1 neurons (1), MP3 has divided into the H-cell (H) and H-cell sib (HS) neurons,
and MP4–6 have divided into iVUM4-6 and mVUM4-6. The MNB has delaminated
and will soon initiate division. AMG (dark gray) and PMG (light blue) are beginning
their inward migration. In this ﬁgure and others, the red bracket shows the extent
of the midline neurons and precursors, the gray bracket indicates AMG and blue
bracket indicates PMG.
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1998; Morel and Schweisguth, 2000; Zinzen et al., 2006). Expres-
sion is maintained in the midline primordium from stages 9–11 by
two distinct autoregulatory enhancers, one adjacent to PE (sim-3.7,
which also contains the above-mentioned initiation element)
(Nambu et al., 1991; Wharton et al., 1994) and the other adjacent
to the sim late promoter (PL; sim-1.0) (Supplementary Fig. S1A;
Freer et al., 2011; Muralidhar et al., 1993). These enhancers
together provide uniform expression in all midline cells from
stages 5–11, as indicated by GFP protein accumulation throughout
the midline primordium (Fig. 3B, C; green). The PE mesectodermal/
midline primordium enhancer is located in intron 1 within the
sim-3.7 fragment and the PL midline primordium enhancer is
located in the 50-ﬂanking sim-1.0 fragment. While a sim-3.7-Gal4
transgene can drive expression in the mesectoderm (Fig. 3A), it
ceases activity in most midline cells by stage mid 11 (Fig. 3B;
magenta). In contrast, sim-1.0 activates expression in all midline
cells starting at stage 9, and continues activity in all midline cells
throughout stage 11, as detected by Gal4 transcripts (Fig. 3C;
magenta). Thus, the sim gene is an example of multiple enhancers
functioning together to control levels of midline primordium
expression, each active throughout the mesectoderm/midline
primordium at successive stages. Through much of the stages
9–11 interval, their expression completely overlaps in all midline
primordium cells, but by mid stage 11 (s11(m)), sim-1.0 predomi-
nates as the sim-3.7 enhancer fades. However, it is interesting that
both sim enhancers are off after stage 11, indicating active
processes that discontinue autoregulatory-induced transcription.
How this is achieved at the cis-control level is unknown.
Sema-1b
Of the genes analyzed, Sema-1bmost closely resembles sim due
to its uniform expression in the mesectoderm from stages 5–8
while continuing to be expressed in midline primordium cells
from stages 9–11 (Fig. 2D–F, S). Testing genomic fragments from
the Sema-1b locus for midline expression (Supplementary Fig.
S1B), we identiﬁed a single 580 bp fragment from the ﬁrst intron
that recapitulated Sema-1b mesectodermal (Fig. 3D) and midline
primordium (Fig. 3E, F, H; green) expression, including a reduction
in newly formed neurons (Fig. 3F; magenta). Like sim, the
mesectodermal pattern of Sema-1b suggested that Dorsal, Sna,
Twi, and Notch potentially initiate its expression at stage 5. Indeed,
BDTNP ChIP–chip data for Dorsal, Sna, and Twi detected peaks
centered on Sema-1b-580 (Supplementary Fig. S1B; MacArthur et
al., 2009). Two Twist consensus binding sites, T1 and T2 (CAYRTG)
(Zeitlinger et al., 2007), were identiﬁed and separately mutated
(the T2 site overlaps a CME; Sonnenfeld et al., 1997; Wharton et al.,
1994) (Fig. 3G). In addition, a perfectly conserved E-box sequence
(CANNTG) that could potentially bind Twi or another bHLH protein
was present. Mutation of T1 along with the E-box site (mut-E-T1)
had no effect on expression (Fig. 3G, I), whereas mutation of the
T2/CME site in combination with two other CMEs (mut-CME-T2)
resulted in an absence of Sema-1b-580 expression (Fig. 3G, J).
In contrast, mutation of two conserved Su(H) YRTGDGAA con-
sensus sites (mut-Su(H)) (Barolo et al., 2000) did not alter Sema-
1b-580 expression (Fig. 3G, K). As mentioned, mutation of the
three CMEs (Sema-1b-580-mut-CME-T2), which also included
mutation of an overlapping Twi site, resulted in loss of both
mesectodermal and midline primordium expression. However,
analysis of homozygous sim null mutant embryos indicated that
loss of sim affects only midline primordium expression (stages 9–
11) (Fig. 3N, O) but not mesectodermal expression (stages 5–8)
(Fig. 3L, M). This result conﬂicts with a report that Sema-1b
expression is sim-independent (Khare et al., 2000). This previous
observation may have examined only early, sim-independent
expression of Sema-1b. Our interpretation of these results is that
Sim:Tgo directly regulates Sema-1b midline primordium expres-
sion, and Twi controls mesectodermal expression in conjunction
Fig. 2. Common patterns of midline primordium gene expression. (A–R) Midline primordium expression (magenta) of 6 genes revealed by (A–C) anti-Sim staining, or (D–R)
in situ hybridization of sim-Gal4 UAS-tau-GFP embryos. Stages shown are: stage 10 (s10), early stage 11 (s11(e)), and late stage 11 (s11(l)). Horizontal views of whole embryo
maximum projections, with ﬁrst and last confocal slices selected to emphasize CNS midline expression, are shown for stage 10 embryos, and sagittal views of single
segments are shown for stage 11 embryos. Embryos are co-stained with anti-tau (green) to outline midline cells. The red, white, and blue lines correspond to the lines in
Fig. 1 and mark midline neural precursors and neurons (red), AMG (white), and PMG (blue). Arrowheads point to delaminating MP4s or their iVUM4/mVUM4 progeny, which
act as developmental timing and positional markers. Anterior is to the left. (S) Timeline of midline expression of 6 genes depicted in A–R. Stages are shown at the top.
(T) Schematic of dynamic midline primordium gene expression during stage 11. Midline cells are depicted as in Fig. 1, and all cells initially express each gene (magenta). As
MPs delaminate and divide, they reduce expression, resulting in regions of low (pink) or no (white) expression in the interior of each segment by late stage 11.
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with Dorsal and Sna. The absence of Sema-1b-580 mesectodermal
expression when all 3 CMEs were mutated is due to the loss of Twi
binding (and not Sim:Tgo).
In summary, a single enhancer that is directly regulated by Sim:
Tgo controls both Sema-1b mesectoderm and midline primordium
expression, while sim utilizes at least three enhancers to achieve a
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similar pattern. Sema-1b expression is reduced in a subset of
midline cells at stage 11, even though Sim protein is present. Thus,
the inﬂuence of sim on Sema-1b expression is lost, just as with sim
autoregulation. While the stage 11 pattern resembles Notch mid-
line activity, the potential regulation of Sema-1b by Notch is not
direct, since mutation of the two consensus Su(H) binding sites
had no effect on transcription.
mfas/Ect-3
The mfas (Hu et al., 1998) and Ect3 genes are closely linked,
separated by 6.0 kb, and they lie in a head-to-head orientation
(Supplementary Fig. S1C). There are two fragments on either side
of the mfas promoter that drive expression in subsets of midline
cells: mfas-590 drives sporadic expression in PMG and MNB and
its progeny starting at stage 13 (data not shown), while mfas-780
drives early expression in MP4-6, as well as sporadic expression in
AMG at stage 10 (Fig. 3P). The expression controlled by these
enhancers was not sufﬁcient to recapitulate the midline primor-
dium expression of mfas during stages 10–11 (Fig. 2M–O, S). One
fragment 50 to the Ect3 promoter and another fragment from
intron 1 (Supplementary Fig. S1C) are also active in midline cells:
the intronic Ect3-1.8 fragment promotes strong expression in all
AMG starting at stage 12 (data not shown), while Ect3-3.2
promotes expression in all midline primordium cells during stages
10–11 (Fig. 3Q; green), although there was a noticeable reduction
in GFP protein accumulation in mVUM4 and iVUM4 (arrowhead),
similar to endogenous Ect3 expression (Fig. 2R). When Ect3-3.2
GFP expression is examined by in situ hybridization, we observed a
reduction in expression in delaminated MPs (Fig. 3R; magenta),
similar to endogenous mfas and Ect3 expression (Fig. 2N, O, Q, R).
Since only a single pan-midline primordium enhancer was
detected in the regions of mfas and Ect3 that can recapitulate
endogenous expression of both genes, we suggest that the Ect3-3.2
enhancer is shared between mfas and Ect3.
Tl
The Tl-950 fragment drives midline reporter gene expression
from stages 9–13 (Wharton and Crews, 1993). It contains 4 CMEs
that are required for midline expression (Wharton et al., 1994). We
examined Tl-950 in greater detail, observing that it is expressed in
all midline primordium cells beginning at stage 9 until stage 11
(Fig. 3S; green shows GFP accumulation from earlier stages).
However, during stage 11 Gal4 transcription is restricted from
delaminating MPs and the posterior cells of each segment (Fig. 3S;
magenta). Thus, the Tl-950 fragment has a single midline enhancer
capable of exactly recapitulating endogenous expression of Tl
(Fig. 2J–L).
Summary
Gene expression in the midline primordium is characterized by
expression in all midline cells followed by alterations in the
expression pattern as midline cells begin to divide, migrate, and
differentiate. Transgenic enhancer analysis of these 5 genes (and
rho; see below) has successfully identiﬁed enhancer elements that
recapitulate midline primordium expression, revealing that either
a single enhancer or two enhancers that function together can
generate the simple midline primordium expression pattern. In
addition, two genes may share the same enhancer. The genes
analyzed maintain expression in MG but not midline neurons, and
this expression is controlled by the identiﬁed enhancers. Thus,
although Sim is present in all midline cells through stage 11, its
presence is unable to drive expression in midline neurons,
indicating both a limitation of its activity and the existence of
mechanisms that differentially control midline glial and neuronal
expression.
Multiple enhancers generate the rhomboid midline primordium
expression pattern
The rho gene encodes a protease involved in Drosophila Spi
signaling and plays an important role in generating a diffusible
midline Spi signal (Golembo et al., 1996; Kim and Crews, 1993).
The rho gene is expressed throughout the midline from stages 6 to
early stage 11 (Fig. 2G, H, S; Fig. 4A–D). Following a transient burst
of expression in delaminated MPs before division (Fig. 4B, B0;
yellow and white arrowheads), post-mitotic midline neurons show
reduced expression at mid and late stage 11 (Fig. 4C, C0 arrows; D,
D0 bracket), while AMG and PMG maintain expression. There exist
multiple rho midline enhancers (Fig. 4I, Supplementary Fig. S1D),
and we initially focused on a previously identiﬁed enhancer that
controls midline primordium expression (rho-365; Ip et al., 1992;
Zelzer and Shilo, 2000). The rho-365-GFP transgene promoted only
weak and sporadic GFP in the midline at stages 6–8 (not shown),
resolving to expression in cells underneath the recently delami-
nated MP4 (Fig. 4E, arrowhead) during stages 9–10. These cells
could be either MG or midline neural precursors (MPs or MNB) yet
to delaminate. Expression progressed posteriorly in each midline
segment (Fig. 4F, blue bracket), then into the anterior-most cells of
each segment (Fig. 4G, white bracket). However, after each MP
delaminated during stage 11, GFP expression ceased in that cell
and its progeny (Fig. 4H, red bracket), similar to endogenous rho.
Thus, rho-365 progressively expands in midline cells during stages
10–11. This differs from other midline primordium enhancers that
show uniform midline expression prior to stage 11, then lose
expression in neurons after delamination.
While rho-365 expression mirrored much of the spatial
dynamics of rho expression during stage 11, it did not recapitulate
the burst of expression seen occasionally in the MPs (compare
Fig. 4B, B0 to F, J), nor earlier mesectoderm or midline primordium
expression. This lack of expression was not due to a partial
enhancer, as similar results were observed with a larger fragment,
rho-2.2 (Fig. 4I, K, Supplementary Fig. S1D, S2), which includes
neuroectodermal and tracheal enhancers and promoter sequences
(Ip et al., 1992).
To ﬁnd additional rho regulatory sequences, we used annota-
tions of Drosophila embryonic DNaseI hypersensitive regions
(Thomas et al., 2011) and noticed open chromatin regions at the:
(1) rho promoter, (2) rho-365, and (3) an upstream region with
enhancer activity in larval wing discs (Reeves and Posakony, 2005)
Fig. 3. Midline primordium enhancers control broad and restricted midline expression. (A–F) in situ hybridizations of sim-3.7-Gal4, sim-1.0-Gal4, and Sema-1b-580-Gal4
embryos with a Gal4 probe showing midline expression (magenta) at stages 5 (s5), 6 (s6), early 11 (s11(e)) and mid 11 (s11(m)). (A,D) Horizontal views are shown with
mesectodermal stripes indicated by arrowheads. (B, C, E, F) Shown are maximum projections of two adjacent sagittal view confocal slices of abdominal midline segments
from embryos containing either UAS-tau-GFP or UAS-mCD8-GFP and stained with anti-GFP to visualize GFP accumulation due to the activity of each enhancer throughout the
midline primordium (green). White arrowhead indicates delaminated MP4, red brackets cover midline neurons and MPs, white and blue brackets show the locations of AMG
and PMG, respectively. (G) Schematics of Sema-1b-580 and mutant variants showing potential CME, Twist (T1, T2), and Su(H) binding sites. Width of each block corresponds
to the length of consensus binding sites and the presence of a black border indicates an aligned sequence with 100% identity in all species examined. A conserved E-box
(CANNTG) that was tested in addition to canonical Twist sites is indicated with (*). Midline expression of the reporter transgene is indicated at right. (H–K) Sagittal views of
constructs schematized in G are shown stained with anti-GFP (reporter expression; green), anti-Sim (midline cells; red), and anti-Engrailed (En) (posterior midline cells;
blue). (L–O) Hybridization of a Sema-1b probe to (L,N) simH9/TM3 heterozygous embryos and (M,O) simH9 homozygous mutant embryos. (P–Q) Expression analysis of mfas,
Ect3, and Tl reporter constructs stained for (P, Q) GFP protein, (R) GFP RNA, and (S) Gal4 RNA. Degenerate nucleotide code: R¼A/G, Y¼C/T, S¼G/C, W¼A/T, K¼G/T, M¼A/C,
B¼C/G/T, D¼A/G/T, H¼A/C/T, V¼A/C/G, N¼A/C/G/T.
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(Fig. 4I). We tested this upstream enhancer (rho-1.0; a gift from J.
Posakony) for embryonic activity, and observed sporadic expres-
sion in all midline cells during stages 10–11, with the most
consistent expression in the neurons derived from MP3 and MP4
(Fig. 4L), the cells with the most consistent “burst” of endogenous
rho expression. Thus, together, the rho-365 and rho-1.0 fragments
recapitulate the endogenous pattern of rho midline primordium
expression during stage 11. The rho-1.0 fragment has a single CME,
and a subfragment lacking this site (rho-785, Fig. 4I) failed to drive
midline expression, indicating essential sequences in the deleted
region (data not shown). The larger rho-2.3 fragment has a total of
4 CMEs and drives broader, more variable, expression in all
Fig. 4. Multiple enhancers collaborate to control rhomboid midline primordium expression. (A–D0) Expression dynamics of rho (magenta) is shown in representative
segments in sim-Gal4 UAS-tau-GFP (sim-tau-GFP) embryos also stained with anti-tau (green). Stages shown are: (A, A0) stage 10, (B, B0) early stage 11 showing a burst of rho
expression in MP3 (yellow arrowhead) and MP4 (white arrowhead), (C, C0) mid stage 11 in which neuronal progeny (arrows) show reductions in expression, and (D, D0) late-
stage 11 showing low levels of rho expression in neurons (below red bracket). (E–H) rho-365-GFP embryos stained for GFP RNA (green) and Sim protein (blue). (E) Arrowhead
indicates the presence of strong GFP in a small number of midline cells at stage 10. (F) GFP expression expands posteriorly in midline cells, but is restricted from iVUM4/
mVUM4 (white arrowhead). (G, H) Reduction of GFP expression is apparent in midline neurons beneath the red bracket, but is maintained in AMG (white bracket) and PMG
(blue bracket). (I) Schematic of rho locus showing features related to gene expression. Genomic fragments with midline activity are indicated as green boxes; rho-785 does
not have midline activity. Consensus Sim:Tgo binding site matches (ACGTG) are indicated as red boxes, and the presence and extent of open chromatin regions (DNase I
hypersensitive sites, 5% FDR, adapted from genome.ucsc.edu) at stage 10 are indicated by lines. (J–M) Embryos containing rho midline fragments driving GFP expression at
mid-stage 11 stained for GFP, Sim, and En. (J, K) Arrowheads point to neurons with reduced expression.
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midline cells compared to rho-1.0 (Fig. 4M), but did not drive
strong mesectoderm expression. In summary, multiple enhancers,
including the rho-1.0 enhancer, the rho-365 enhancer, and an
unidentiﬁed mesectodermal enhancer collaborate during stages
6–11 to drive dynamic midline expression of rho.
Multiple conserved cis-regulatory motifs reside within the rho-365
midline enhancer
To identify potential sequences in rho-365 required for midline
expression, we compared the rho-365 sequence to orthologous
regions from all sequenced Drosophila species, analyzing these
sequences for conserved motifs matching known midline regula-
tory sites (Estes et al., 2008; Fulkerson and Estes, 2011; Ma et al.,
2000; Pearson et al., 2012; Wharton et al., 1994) and novel over-
represented motifs (Fig. 5A). Two CMEs, both highly conserved in
Drosophila species, are within the rho-365 interval (also noted in
Hong et al., 2013; Zelzer and Shilo, 2000; pink C1, C2). The second
CME (C2) is not present in D. pseudoobscura or D. persimilis, but a
potential compensatory site arose promoter-distal to the ﬁrst CME
(C1). Overlapping the C1 CME is a consensus high-afﬁnity site for
Su(H) (blue). In the conserved block promoter-distal to the ﬁrst
CME is a sequence ATGCGTG (Fig. 5A, Motif-A; magenta) that is
ATACGTG in the distantly related virilis group, including D. virilis
(note that ACGTG matches the CME). In all species where Motif-A
contains GCGTG, a Sox-family binding site (ACAATG) is adjacent
(Fig. 5A; green); the Drosophila Sox factor Dichaete regulates
midline expression of several genes (Estes et al., 2008; Ma et al.,
2000; Sanchez-Soriano and Russell, 1998) and Dichaete ChIP–chip
experiments show a peak encompassing rho-365 (Negre et al.,
2011; Thomas et al., 2011). There is also a conserved TAGteam
consensus binding site (YAGGYAR; purple), recognized by Zelda, a
transcription factor shown to regulate midline expression of link
(Pearson et al., 2012). Zelda ChIP-Seq detected binding to the rho-
365 region at stages 10-11 (Harrison et al., 2011). Finally, there is a
conserved repeat sequence (GATTTAYGAWG; tan). To determine
the contributions of these sites to rho-365 midline expression,
each site was mutated and the altered sequences tested in vivo
(results summarized in Fig. 5B).
CME and motif-A sequences synergistically control rho enhancer
expression
It was previously reported that a rho-lacZ enhancer trap drove
low levels of expression in homozygous sim null mutant embryos
(Nambu et al., 1990). We observed similar results for rho-365; GFP
levels were strongly reduced, but present, in the midline cells of
sim mutant embryos (Fig. 6A, B). However, endogenous rho
transcripts were not detected in midline cells in sim mutants at
stages 10-11 (data not shown), suggesting that trace rho-lacZ and
rho-365 GFP were due to early, sim-independent expression in the
mesectoderm. Thus, sim is required for midline primordium
expression of rho. To conﬁrm that sim directly regulates rho
midline expression through rho-365, we mutated the two CMEs,
both individually (CME1, CME2) and together (CME12) (Fig. 5B)
and tested the mutated transgenes in vivo. When both CMEs were
mutated together, rho-365 expression was only slightly reduced in
2–3 MG in the middle of each segment (compare Fig. 6C, C0 to
Fig. 4J). We note that Hong et al. (2013) mutated the same
sequences and observed a much greater reduction in expression;
this could be due to a number of factors including differences in
the mutated sequences, transformation systems, or staining con-
ditions. We observed a similar result when CME1 alone was
mutated, whereas mutation of CME2 alone had no effect. The lack
of the strict requirement of the CMEs for rho-365 expression,
contrasted with sim mutants that have a much stronger effect,
suggested that sim controls rho-365 expression in part indirectly
or via non-canonical Sim binding sites.
Motif-A consists of the sequence, ATGCGTG, that itself contains
a sequence (GCGTG) that differs from a Sim:Tgo binding site
(ACGTG) by a single base pair change. DNA binding experiments
examining the in vitro DNA speciﬁcity of Drosophila Sim partnered
with mammalian Arnt (ortholog to Drosophila Tgo) (Swanson et al.,
1995) showed binding to GCGTG, although most other experi-
ments have described ACGTG as being the unique binding site for
Sim:Tgo or Sim:Arnt (see Discussion). In D. virilis and other distant
Drosophila relatives of D. melanogaster, the orthologous Motif-A
sequence is ACGTG (Fig. 5A) instead of GCGTG. While this
sequence is recognized by both Spineless (Ss):Tgo (Emmons et
al., 1999) and Dysfusion (Dys):Tgo bHLH-PAS proteins (Jiang and
Crews, 2007), neither ss nor dys is expressed in embryonic midline
cells as detected by in situ hybridization, immunostaining, or RNA-
seq on puriﬁed midline cells (Fontana and Crews, 2012).
Fig. 5. Functional analysis of rho-365 DNA sequence motifs. (A) Schematic of the
rho-365 sequence and representative orthologous sequences among sequenced
Drosophila species. Vertically aligned motifs indicate likely orthologous sequences;
sequence lines are not drawn to scale. Species shown are: D. melanogaster (Dmel),
D. pseudoobscura (Dpse); D. willistoni (Dwil), and D. virilis (Dvir). The two CMEs are
indicated by C1 and C2. Note that the ﬁrst Repeat motif site (orange) in D. willistoni
contains a mismatch compared to the D. melanogaster sequence. (B) Mutations
were generated in Dmel rho-365 and tested in vivo for midline expression. Absence
of a colored block indicates mutation of that sequence; conversion to a different
color indicates that the motif was changed to a different motif. Midline expression
levels (GFP protein accumulation at s11(m)) were indicated as follows: (þþþ)
normal levels and pattern, (þþ*) slight reduction in a subset of cells, (þþ) slightly
reduced expression, (þ) weak but consistent expression; (þ/) nearly undetect-
able expression, and () no expression.
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It is of note that Motif-A (ATGCGTG) also resembles a part of a
POU homeodomain POU-speciﬁc box DNA binding site (ATGC),
and the Ventral veins lacking (Vvl) POU homeodomain protein
(binding site WWATKMR; Fly Factor Survey; Zhu et al., 2011) has
been implicated in controlling midline transcription (Estes et al.,
2008; Ma et al., 2000; Sanchez-Soriano and Russell, 1998).
Fig. 6. Direct and indirect regulation of rho by Sim. (A, B) Horizontal views of rho-365-GFP embryos in posterior segments at stage 11 in: (A) sim heterozygous and (B) sim
homozygous mutant embryos, detecting GFP. In B, the white line indicates the location of the ventral midline. (C–F) Sagittal views of stage 11 single segments of rho-365 site
variants, detecting GFP (green), Sim (red), and En (blue) (compare to Fig. 4J): (C) rho-365-CME12; (D) rho-365-Motif-A; (E) rho-365-Motif-A CME12; (F) rho-365-Motif-A4CME
CME12. (C0–F0) Same images as (C–F), but showing only the GFP channel. (C, D, F) Arrows point to MG with reduced GFP. (E) Arrow points to several posterior midline cells with
weak GFP. (G, H) Horizontal views of stage 11 prd-Gal4/UAS-sim embryos stained for (G) Sim and En or (H) rho; brackets indicate expanded expression. (I–L) Stage 11 prd-Gal4 UAS-
sim embryos containing rho-365-GFP either: (I) unmutated (Unmut) or with (J) CME12, (K) Motif-A4CME CME12, or (L) Motif-A mutations. The bracket indicates a domain of
expanded expression, except for (L) in which there is no signiﬁcant expanded expression, while expression remains strong in the midline primordium (white arrowhead).
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Mutation of the POU-homeobox motifs in a midline enhancer from
the wrapper gene did not reduce expression (Estes et al., 2008), but
was required for MG expression of a vvl autoregulatory midline-
speciﬁc enhancer (Certel et al., 1996). Expression of rho-365-
Unmut or rho-365-CME12 was not affected in a vvl mutant (data
not shown), suggesting that Vvl is not the sole regulator binding
Motif-A; this is consistent with previous observations that exam-
ined expression of a larger fragment containing rho-365 in vvl
mutants (Zelzer and Shilo, 2000). One caveat to this interpretation
is that other works showed only a small reduction of slit MG gene
expression in vvl mutants except in the context of a Dichaete
mutant (Ma et al., 2000; Sanchez-Soriano and Russell, 1998).
We tested the requirement of Motif-A for midline expression,
alone and in conjunction with CMEs. Mutating Motif-A alone
caused a reduction in GFP within central MG, similar to mutating
both CMEs (Fig. 6D, D0). However, mutation of Motif-A and both
CMEs together (Fig. 6E, E0) caused a dramatic reduction in GFP
protein in all cells, with trace expression remaining only in
posterior cells with the strongest Notch signaling: MP6, MNB,
and PMG (Wheeler et al., 2008). Thus, the Motif-A binding site
synergizes with the CMEs to activate expression in many midline
cells. Changing the Motif-A GCGTG to ACGTG CME along with
mutation of the two CMEs (Motif-A4CME, CME12) (Fig. 6F, F0) did
not abolish expression like the Motif-A CME12 mutation. Instead,
expressionwas similar to CME12. Since it did not affect expression,
it is consistent with Sim:Tgo being able to bind both ACGTG and
GCGTG (Motif-A), although since the single G4A change may also
not have affected binding of some other transcription factor.
To provide additional insights into whether Motif-A is recog-
nized by Sim:Tgo in rho-365-GFP, we ectopically expressed sim in
the lateral ectoderm using prd-Gal4 (Estes et al., 2001), causing
stripes of Sim protein to be produced in alternating segments
(Fig. 6G; bracket) and assayed rho and various rho-365 reporters.
Ectopic sim expression in the ventral ectoderm is sufﬁcient to
cause ectopic expression of midline-speciﬁc genes, including rho
(Fig. 6H) (Estes et al., 2001; Nambu et al., 1991; Zinzen et al., 2006).
rho-365 GFP expanded in a similar manner to rho (Fig. 6I),
conﬁrming that sim is genetically upstream of rho-365. rho-365-
CME GFP also expanded, but with lower expression levels (Fig. 6J).
Similar results were obtained with Motif-A4CME CME12 GFP
(Fig. 6K). In contrast, rho-365-Motif-A GFP did not expand laterally
(Fig. 6L), although midline expression was maintained. This result
adds additional complexities to rho midline expression, indicating
the presence of a factor, in addition to Sim, that functions in the
midline but not lateral CNS. The function of this factor is compen-
sated by the activity of the Motif-A site, but in the absence of
Motif-A, its function is revealed. This experiment also indicates
that even if Sim:Tgo binds both Motif-A and the canonical Sim
sites, the Motif-A (ATGCGTG) and CME12 (ACGTG) binding sites
are not functionally equivalent.
Notch signaling directly regulates rhomboid midline expression
Notch signaling regulates multiple aspects of midline develop-
ment and transcription during stage 11 (Wheeler et al., 2008),
although no direct transcriptional targets have been identiﬁed. The
presence of a conserved, high-afﬁnity Su(H) binding site in rho-
365 (Fig. 5A) suggested that Notch signaling directly regulates rho
midline expression. Furthermore, both endogenous rho gene
expression and rho-365-GFP expression resembled expression of
a Notch reporter, 12xSu(H)bs-lacZ (Wheeler et al., 2008), as did rho-
365-CME12-GFP (Fig. 7A0–D0), which we compared directly to
12xSu(H)bs-lacZ transcription (Fig. 7A–D). The results indicated
that: (1) both reporters are strongly expressed in the same midline
cells underneath the delaminated MP4 at stage 10 (Figs. 4E, 7A, A0;
white arrowheads), (2) both expand posteriorly in undifferentiated
MPs, MNB, and PMG in early and mid stage 11 embryos (Figs. 4F,
7B, B0, C, C0; blue brackets); (3) both are present in AMG, but
12xSu(H)bs-lacZ expression and rho-365-CME12-GFP are lower
than rho-365-GFP (Fig. 7C, C0; gray brackets; compare to Fig. 4G),
and (4) expression of both reporters remains high in PMG and
MNB but low elsewhere, including midline neurons and AMG
(Fig. 7D, D0; beneath red brackets; compare to Fig. 4H). This
pattern of activation explains the reduced accumulation of GFP
protein in a subset of AMG in rho-365-CME12-GFP embryos
(Fig. 6C, compare to Fig. 4J); the CMEs are required for maintaining
transcription in midline cells with transient Notch signaling.
To further explore the role of Notch signaling in rho-365
regulation, a transgene encoding a constitutively-active form of
Su(H), Su(H). VP16 (Kidd et al., 1998), was expressed throughout
the midline from stages 5–11 using Sema-1b-580-Gal4. This
resulted in strong accumulation of rho-365 GFP (Fig. 7E), including
the presence of GFP in cells that normally do not express rho-365-
GFP, such as MP1 (green arrowhead), MP3 (yellow arrowhead),
and MP4 (white arrowhead). In contrast, levels of rho-365 GFP
were not signiﬁcantly affected when UAS-Su(H).VP16 was driven
by sim-1.0-Gal4 (Fig. 7F); sim-3.7-Gal4 expanded GFP into MP1,
MP3, and MP4 at a lower frequency (data not shown). The
differences in the results with different midline drivers are likely
due to the strength and timing of Gal4 transcription; in particular,
the later and weaker expression of sim-1.0 compared to Sema-1b-
580. This indicates that the timing and/or magnitude of Notch
signaling are critical in driving midline expression.
Consistent with a regulatory role for Notch signaling, rho-365
GFP accumulation was greatly reduced in embryos mutant for
Delta, which encodes a Notch ligand (Fig. 7G). Finally, mutating a
single nucleotide in the Su(H) binding site, previously shown to
abolish binding (Bailey and Posakony, 1995), also strongly reduced
midline GFP (Fig. 7H). These results indicate that Notch signaling
and Su(H) directly activate rho expression in the midline primor-
dium. However, other factors must restrict rho expression to
midline cells, because rho-365 is midline-speciﬁc, whereas Notch
signaling is active throughout the embryo.
The relative positions of the Su(H) and Sim:Tgo binding sites inﬂuence
rhomboid enhancer function
Sim:Tgo binding site CME1 overlaps the Su(H) binding site,
which raises interesting possibilities regarding interactions
between these transcription factors. One hypothesis is that com-
petition between Sim and Su(H) may explain the rho-365 expres-
sion dynamics at stage 11. For example, Su(H) acts as a repressor
(Su(H)R) in the absence of Notch signaling (Barolo et al., 2000;
Morel and Schweisguth, 2000); if Sim:Tgo binds to the shared
sequence, formerly bound by Su(H) activator (Su(H)A) that was
present during transient Notch signaling, it could compete with
Su(H)R to maintain expression. This model is consistent with the
loss of rho-365 MG expression when CMEs are mutated (rho-365-
CME12-GFP) after the period of Notch signaling (Fig. 7C0, D0). To test
this model, we separated CME1 from the Su(H) site in the context
of rho-365. This model predicts that if the CME1 and Su(H) sites are
separated, then Su(H)R will be more difﬁcult to displace and rho-
365 expression levels will be reduced or delayed. First, we
duplicated a 10 bp sequence containing both the CME1 and Su
(H) sites, which slightly increased GFP levels but had no effect on
the midline expression pattern (Fig. 7I, J). This control provided a
platform for testing the signiﬁcance of site position, as described
below. Mutating either the ﬁrst (Fig. 7K) or second pair (Fig. 7L) of
CME/Su(H) sites had only small effects on midline expression,
conﬁrming that the absolute position of the shared CME/Su
(H) site was ﬂexible. Mutating the ﬁrst Su(H) site along with the
second CME site maintained wild-type expression (Fig. 7M),
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demonstrating that competition for binding did not control the rho-
365 expression pattern. Even ﬂipping the orientation of the CME
did not affect expression (Fig. 7N). However, mutating the ﬁrst CME
site and the second Su(H) site, which places the Su(H) site 50 to the
CME, dramatically reduced expression levels (Fig. 7O, P). Thus, the
relative positioning of the CME and Su(H) sites is important, and
Fig. 7. Notch/Su(H) directly regulates rhomidline expression. (A–D0) Sagittal views of single segments of 12xSu(H)bs-lacZ; rho-365-CME12-GFP embryos, stained for Sim (blue) and
(A–D) lacZ (magenta) or (A0–D0) GFP (green). Embryonic stages examined were (A, A0) stage 10, (B, B0) early stage 11 (s11(e)), (C, C0) mid stage 11 (s11(m)), and (D, D0) late stage 11
(s11(l)). (A) Yellow brackets indicate lacZ expression in non-midline ectodermal cells, and white brackets indicates lacZ expression in midline cells. (C0 , D0) White arrows point to
reduced apical GFP expression in posterior-most AMG compared to rho-365-GFP (Fig. 4G, H). (E–H) Stage 11 rho-365-GFP in genetic backgrounds with altered Notch signaling,
stained for GFP (green), Sim (red), and En (blue). (E) Sema-1b-580-Gal4/UAS-Su(H). VP16; rho-365-GFPmidline segment with strong GFP staining in all midline cells, including MP1
(green arrowhead), MP3 (yellow arrowhead), and MP4 (white arrowhead). (F) sim1.0-Gal4/UAS-Su(H). VP16; rho-365-GFP embryo showing GFP levels similar to rho-365; note
absence of staining in midline neurons from MP3 and MP4. (G) rho-365-GFP in a Dl mutant. (H–P) rho-365-GFP Su(H) and CME site variants, stained for GFP, Sim, and En. (H) rho-
365-GFPwith a single base change in the Su(H) binding site. (I–P) rho-365-GFPwith the overlapping CME/Su(H) sequences altered as indicated below each image. CME is boxed in
red, and the Su(H) binding site is boxed in blue. Positions “A” and “B” indicate the ﬁrst or second positions in duplicated sequences.
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altering the native positioning may interrupt interactions with
nearby transcription factors. However, the overlap between the
CME and Su(H) sites is unlikely to be important and more likely
coincidental (Lusk and Eisen, 2010).
Sox factor binding sites and a novel repeated motif contribute to
rhomboid enhancer function
Several additional sequences are present in rho-365 (Fig. 5A)
that are conserved and correspond to binding sites for known
midline regulators. Both the TAGteam (YAGGYAR) and Sox
(ACAATG) binding site sequences are similar to known binding
sites for Zelda and Dichaete, respectively. Both of these proteins
control midline transcription, and ChIP experiments detected
binding by both factors in multiple locations within the rho locus,
including rho-365. In addition, a repeated sequence (consensus
GATTTAYGAWG), discovered by WinDotter analysis (Sonnhammer
and Durbin, 1995), was found in two conserved positions, which is
unlikely to occur by chance in such a short sequence.
To test the possible function of these sites on rho-365 midline
expression, each site was mutated and analyzed in vivo (Fig. 5B).
The single site matching the TAGteam (Zelda consensus) sequence
was mutated, but no alteration in GFP levels was observed in rho-
365-TAGteam (Fig. 8A, A0). Similarly, no change in expression was
observed with rho-365-CME12-GFP in a zelda null mutant strain
(data not shown).
Several Sox family genes are expressed in the midline at stage
11, including Dichaete, Sox-Neuro (SoxN), and Sox14 (Fontana and
Crews, 2012; Ma et al., 2000; Sanchez-Soriano and Russell, 1998).
Mutants for Dichaete are defective in MG transcription (Ma et al.,
2000; Sanchez-Soriano and Russell, 1998), and the wrapperG
enhancer requires Sox consensus sites for robust midline expres-
sion (Estes et al., 2008). The single match to the Sox consensus in
rho-365 is between the Motif-A sequence and CME1; however, this
site is present only in species where Motif-A contains GCGTG.
With species such as D. virilis, that have a CME instead of Motif-A,
there is no Sox site. This Sox site was tested for a role in rho-365
function alone and in combination with both CMEs mutated.
When the Sox site was mutated alone, expression was abolished
in nearly all midline cells, but approximately one cell per segment
maintained wild-type levels (Fig. 8B, B0). Mutating both CMEs
along with the Sox site abolished detectable GFP (Fig. 8C, C0).
However, no changes in rho expression were observed in a
Dichaete mutant. Thus, another transcription factor, not Dichaete,
may bind to this sequence, or Dichaete's genetic function is
compensated by other transcription factors, as previously shown
(Buescher et al., 2002; Ma et al., 2000; Overton et al., 2002;
Sanchez-Soriano and Russell, 1998).
We tested the requirement of the Repeat sequences, by mutat-
ing each site individually, as well as together. Mutation of either
site by itself had little effect on expression (data not shown), but
mutating both together dramatically reduced expression (Fig. 8D,
D0). There was a low level of expression in all midline cells except
the progeny of MP1, MP3, and MP4, suggesting that the unknown
factor recognizing this sequence acts as a general activator without
providing patterning information. There was relatively little
sequence conservation in the 50 region of rho-365, suggesting an
absence of additional important transcription factor binding sites
in this region. Consistent with this observation, deletion of an
AvaII fragment that removes the 50 72 bp (Fig. 5B) showed no
alteration of midline expression, indicating no essential elements
in that region.
Single-minded and pointed directly control argos expression
Another midline-expressed gene regulated by intercellular cell
signaling is argos (aos), which is a downstream target of Spi
signaling in MG (Stemerdink and Jacobs, 1997). Aos inhibits Spi
signaling in a negative feedback loop. The Pointed (Pnt) ETS
transcription factor is the transcriptional effector of Spi signaling,
and aos MG expression is absent in pnt mutants (Stemerdink and
Jacobs, 1997). We identiﬁed a fragment, aos-0.5, in intron 1
(Supplementary Fig. S1E) that drives reporter gene expression in
a subset of MG (Supplementary Fig. S3A, B), similar to endogenous
aos; however, aos-0.5 is not expressed in all cells that are
responsive to Spi signaling (Gabay et al., 1997). Expression of this
fragment responds to spi signaling, since expression is enhanced
when pnt is overexpressed in midline cells (Supplementary Fig.
S3C) and is greatly reduced when pnt function is inhibited by
midline expression of anterior open (aop; yan), which encodes a
Fig. 8. Sox binding sites and Repeat sequences are required for rho midline expression. (A–D) Sagittal views of embryos containing the indicated rho-365-GFP variants,
stained for GFP, Sim, and En. Variants include mutations in the (A) TAGteam sequence, (B) Sox site, (C) Sox CME12, and (D) Repeats 12. (A0–D0) Same images as A–D, showing
only GFP.
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competitive inhibitor of Pnt (Supplementary Fig. S3D). The aos
gene has 1 CME, which is well conserved in Drosophila species
(Supplementary Fig. S3E, F). When the CME was mutated, expres-
sion was delayed and slightly reduced in a small number of
segments compared to wild-type, but was still present in MG
(Supplementary Fig. S3F–H, J). This indicates, that similar to rho,
sim directly controls aos expression, but the role of the CME is
relatively weak. There are 9 potential ETS transcription factor
binding sites (ETS consensus GGAW; (Wei et al., 2010)) in aos-0.5.
We mutated 4 ETS sites together: one high-afﬁnity site
(SMGGAWRY) (Wildonger et al., 2005; Zhu et al., 2011) and 3
well-conserved GGAW sequences. This resulted in a reduction or
loss of expression (Supplementary Fig. S3I, J), and suggests that
Pnt directly regulates aos expression. Since aos expression is
absent in pnt mutant embryos, it is possible that the additional
ETS sites that were not mutated also contribute to expression.
These data provide additional evidence that midline-expressed
genes responding to cell signaling inputs, such as Notch and Spi,
utilize lineage-speciﬁc regulators, such as Sim, to restrict their
response to the midline cells.
Discussion
Midline primordium expression is generated by diverse enhancer
arrangements
We analyzed fragments from 5 genes, identiﬁed in this and
previous studies, that recapitulate the midline primordium
expression of each gene, including early expression in all midline
cells followed by down-regulation in neurons. Detailed character-
ization of development in the CNS midline cells during differentia-
tion from midline primordium into neurons and glia (Wheeler et
al., 2006, 2008) allowed cell-level comparisons between enhan-
cers with broadly similar midline expression. This analysis
revealed considerable diversity in the architecture of enhancers
driving midline primordium expression.
In the simplest case, both Sema-1b and Tl appear to have a single
enhancer that controls all aspects of midline primordium expression
(“single enhancer” is deﬁned here as a region of DNA that, to date,
has not been subdivided into multiple fragments with midline
primordium expression). An interesting variation of the single
enhancer mode is the linked mfas and Ect3 genes: we propose that
they share a single midline primordium enhancer that resides
between them. While additional midline enhancers may be present
in sequences not yet analyzed, fragments identiﬁed for each gene
generally recapitulate the endogenous embryonic midline primor-
dium expression pattern. In contrast, midline primordium expression
of rho and sim autoregulation is controlled by at least two distinct
enhancers. However, the relative contributions of the two enhancers
are different for the two genes. Midline primordium expression of
sim involves two enhancers that are both expressed in all midline
primordium cells at distinct but overlapping times. Together, they
cover the entire period from stages 9–11. In contrast, the two rho
enhancers are expressed in largely distinct sets of midline cells that
together result in expression in the midline primordium at stages 9–
11. Thus, the two sim enhancers are spatially identical, but differ in a
temporal and quantitative manner, whereas the two rho enhancers
differ spatially. In summary, analysis of midline primordium enhan-
cers from multiple genes indicates the existence of diverse ways to
control a simple expression pattern.
The direct role of single-minded in the control of midline transcription
The sim gene is considered to be a master regulator of midline
transcription based on its requirement for midline cell speciﬁcation,
development, and transcription, and its ability to convert neuroec-
todermal cells to midline cells upon ectopic expression (Crews,
2003). However, questions remain regarding how sim functions at
the molecular level. Experiments from this paper and previous
studies conﬁrm that enhancers that drive midline primordium
expression utilize CMEs, matching the known binding site for
Sim:Tgo. In midline primordium enhancers tested in vivo to date
(sim-1.0, sim-3.7, rho-365, rstF6D-2.5, Tl-950, Sema-1b-580, btl-390),
all showed reductions in midline primordium expression when
CMEs were mutated (Apitz et al., 2005; Freer et al., 2011; Ohshiro
and Saigo, 1997; Wharton et al., 1994). Subsequently, sim is
expressed in all MG, and several MG-expressed enhancers analyzed
(link-285, slit-380 and wrapperG-166) also require CMEs for expres-
sion (Estes et al., 2008; Pearson et al., 2012; Wharton et al., 1994).
While it is reasonable to propose that every gene expressed in Simþ
midline primordium cells and MG is directly regulated by Sim:Tgo,
this needs to be more rigorously analyzed by comparing whole-
genome Sim binding to enhancers of midline-expressed genes.
The rho-365 enhancer has two Motif-A sequences that contain
GCGTG sequences, and their mutation in the context of mutations
of the two CMEs results in a strong reduction in expression. We
and others (Hong et al., 2013) considered whether Sim:Tgo may
also recognize GCGTG to activate midline expression. If true, this
would be the ﬁrst example of Sim:Tgo binding a non-CME
sequence in vivo, and signiﬁcantly expand the possibilities for
Sim control of midline transcription. Numerous studies using
in vivo and cell-based assays have consistently demonstrated
ACGTG to be a recognition sequence of Sim:Tgo (Jiang and
Crews, 2007; Probst et al., 1997; Zhu et al., 2011). Swanson et al.
(1995) used in vitro DNA binding assays to demonstrate that a
heterodimer of Drosophila Sim and mammalian Arnt also bound
GCGTG, as well as ACGTG (Swanson et al., 1995). In contrast,
transient transfection experiments in Drosophila S2 cells showed
that changing ACGTG to GCGTG abolished Sim:Tgo transcriptional
activation of a reporter containing multimerized copies of those
sequences (Jiang and Crews, 2007). However, further work has
revealed that Sim:Tgo binding to CMEs is sensitive to surrounding
DNA sequences (Long et al., 2014; J. Pearson, unpbl.), suggesting
that sequence context can inﬂuence binding. Ultimately, the “Does
Motif-A binds Sim” issue will be resolved by examining whether
Sim:Tgo bind rho Motif-A in vivo using ChIP-seq.
Rhomboid is directly regulated by Notch signaling
Notch plays an important role during the midline primordium
stage, generating midline neural precursors by lateral inhibition
and activating the MG program. A key result from mutational
analyses of rho-365 is that Notch signaling directly regulates rho-
365 enhancer expression via its transcriptional effector, Su(H).
Mutating the Su(H) binding site in rho-365 nearly eliminates
reporter expression, similar to the reduction of expression in a
Dlmutant embryo. However, other midline primordium-expressed
genes are unlikely to be directly regulated by Su(H). The Ect3-3.2,
mfas-780, and sim-1.6 (Hong et al., 2013) fragments do not contain
high-afﬁnity Su(H) consensus binding sites. Mutation of two
Su(H) sites had no effect on Sema-1b-580 enhancer expression,
nor did mutation of a Su(H) binding site in sim-1.0 (J.C.P., unpbl.).
Nonetheless, these genes are genetically downstream of Notch
signaling, in that expression is down-regulated in Notch-
independent MPs soon after the Notch signaling event that
speciﬁes MG (Wheeler et al., 2008). The lack of Notch signaling
in MPs and nascent midline neurons leads to a change in expres-
sion or activity of the direct regulators of these midline
primordium genes.
In addition to direct Notch/Su(H) activation of rho-365, we
identiﬁed at least 4 other motifs: CME (Sim:Tgo), Motif-A, Repeats-
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Fig. 9. Different modes of midline gene control. (A) Sim protein (blue) is present in all midline cells at stages 8–11, and in Notch-dependent cell types at stage 13 (purple
arrow); direct autoregulation is a major aspect of maintained sim expression. Sim arrows indicate direct regulation of the enhancers listed on the right. At stage 11, Sim
regulates midline neuronal (top arrow) and MG (bottom arrow) expression. (B) Sim-Primary role: midline primordium mode of expression in which Sim protein directly
activates high-level expression at stages 9–10 (red). At stage 11, Sim protein function is blocked in neurons, with continued activity in MG and MNB. Activity of these
enhancers is absent during stages 12 and later, despite continued presence of Sim in most midline cells. (C) MG-expressed genes, including link, slit and wrapper, are
regulated by Sim in combination with other transcription factors, such as Zld (blue), Vvl, and Sox proteins (green). Sim provides both temporal (initiation at stage 11) and
spatial (MG-restricted) control. (D) Sim-Secondary role: another model of midline primordium expression, depicted by rho and aos expression, requires initiation by Notch
signaling (magenta), restriction to midline cells by Sim and other midline-speciﬁc factors, Motif-A Binding Protein (MABP) and Midline Speciﬁcity Regulator (MSR). Sox and
Repeat Binding Protein (RBP) (green) also promote activity. (E) The aos gene is activated by a combination of Spi signaling (magenta) via direct binding of Pnt (green) and Sim
(blue). Aos protein inhibits EGF signaling, restricting spi-dependent activity to those MG receiving the most Spi signal. (F) Sim and additional factors confer midline
speciﬁcity. Mesectodermal speciﬁcation is due to the combined action of dorsal-ventral patterning proteins (Dorsal, Twist, and Snail) and Notch signaling. This results in the
midline expression of sim and two postulated regulatory genes whose identities are unknown. MSR is expressed only in midline cells and is not ectopically induced by sim.
Another factor, SIR, is expressed in midline cells as a consequence of sim regulation, since it can be ectopically expressed by sim misexpression. Together these regulators are
involved in directing midline-speciﬁc expression of the rho-365 enhancer and combinations may be in important in regulating additional midline-expressed genes.
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1,2, and Sox. The requirements for each individual motif site was
relatively weak (except for the Sox site), but stronger in combina-
tion. Still, together they are not sufﬁcient for rho-365 midline
expression, since mutation of the Su(H) site nearly eliminates
expression. One or more of these transcription factors are midline-
speciﬁc (e.g. Sim and MSR; see below) and provide the midline
speciﬁcity of rho-365 midline expression. Notch/Su(H) controls the
precise timing and pattern of expression within the midline,
maintaining rho expression within unspeciﬁed midline primor-
dium cells, as well as Notch-speciﬁed MG and MNB. This model
resembles the “Notch plus Proneural” code established for Notch
signaling in lateral inhibition, and found in other examples of cell
signaling control of transcription (for example: Halfon et al., 2000;
Hayashi et al., 2008).
The rho-365 Su(H) site overlaps a CME, and we carried out a
series of experiments to determine if this relationship was func-
tional. We noted that while many alterations to the arrangement
of the CME and Su(H) sites were tolerated, rho-365 expression was
strongly reduced in one particular arrangement of sites (Fig. 7O, P),
demonstrating some constraints on the position and order of the
CME and/or Su(H) sites, relative to adjacent sequences, to promote
midline expression of rho. This resembles the conserved architec-
tural arrangement of Su(H) and sites of Dorsal and Twist required
for regulating neuroectodermal gene expression (Erives and
Levine, 2004).
The Drosophila aos gene possesses a signaling-dependent mid-
line enhancer whose MG expression is directly regulated by Spi
signaling and its transcriptional effector, Pnt (Fig. 9E). Mutation of
the aos CME site, similar to rho-365, did not have a strong effect on
reporter gene expression. In contrast, mutating a subset of
putative ETS binding sites (4/8) reduced expression. Since aos-
500 is quite speciﬁc for MG relative to EGF signaling, these results
are consistent with the hypothesis that Sim helps provide midline
speciﬁcity to Pnt, whose activity may be insufﬁcient to activate aos
by itself.
Progressive modes of midline gene control
The analysis of midline gene transcription described in this and
previous works can begin to describe the progression of midline
transcription during development and demonstrate the diverse
modes for achieving equivalent patterns of expression (Fig. 9). The
sim gene likely plays a role in controlling transcription of all
midline primordium and MG-expressed genes. The Sim protein is
present at high levels at stages 8–11, then is restricted to Notch-
dependent midline cells (AMG, PMG, MNB/progeny, H-cell sib, and
iVUMs 4–6) (Fig. 9A) (Wheeler et al., 2008). The sim gene is
initially transcribed in midline cells by the actions of dorsal–
ventral patterning transcription factors and Notch signaling
(Crews, 2003), and expression is then maintained through stage
11 by two sim-dependent autoregulatory elements residing in sim-
1.0 and sim-3.7. However, these sim enhancer elements cease
activity after stage 11 after which sim expression is present in
only the Notch-dependent cell types. We propose that later sim
expression is dependent on Notch signaling and may also be
maintained by sim autoregulation.
In one common mode of midline target expression (Fig. 9B),
genes such as Ect3, mfas, Tl, rst, and btl are activated by Sim in all
midline primordium cells until stage 11. During stage 11, although
Sim protein is present in midline neurons, it is unable to activate
transcription of these target genes. These genes generally have
3 or more CMEs, and this multiple number may be essential to the
early midline primordium expression as suggested by Hong et al.
(2013). In these enhancers, when the CMEs are mutated, expres-
sion is highly reduced or absent, indicating the strong requirement
of these sites for expression.
Other genes, including link, slit and wrapper, are strongly
expressed beginning at stage 11 and continue expression in MG
(Fig. 9C). Although not expressed at high levels at stages 9–10,
their regulation mechanistically resembles that of genes, such as
Ect3 and Tl (Fig. 9B). Their expression in MG is dependent on Sim,
with additional inputs by transcription factors such as Sox pro-
teins, Vvl (Ma et al., 2000; Sanchez-Soriano and Russell, 1998), and
Zld (Pearson et al., 2012). MG enhancers from slit, wrapper, and
link have a single CME each that are required for MG expression,
and the absence of additional CMEs may be a factor in why their
expression begins later than genes such as sim, Ect3, and Tl, which
have additional Sim:Tgo sites (Hong et al., 2013). However, link
expression is not entirely dependent on its CME, as multiple
binding sites for the MG-expressed transcription factor Zld com-
pensate (Pearson et al., 2012).
Another mode of transcription described in this paper and
Hong et al. (2013) concerns the rho gene, which encodes an
important signaling protein whose midline expression is directly
initiated by Notch signaling (Fig. 9D). There are additional tran-
scriptional regulators of rho, including Sim:Tgo, Sox proteins, and
unknown proteins that bind to Motif-A (Motif-A Binding Protein;
MABP; possibly Sim:Tgo), the Repeat sequences (Repeat Binding
Protein; RBP), and another postulated transcription factor that
confers midline speciﬁcity (Midline Speciﬁcity Regulator; MSR).
Interestingly, the role of the ACGTG binding sites is modest by
themselves, although expression is strongly reduced when other
sequences, such as Motif-A, are also mutated.
In experiments testing the response of rho-365 variants to sim
misexpression, several results suggested the existence of addi-
tional midline-speciﬁc regulatory factors (Fig. 9F). When the
Motif-A mutant variant of rho-365 was examined in sim misex-
pression embryos, GFP expression was not induced laterally,
although it was present in midline cells (Fig. 6L). One interpreta-
tion of this result is that there exists a midline regulatory factor
(MSR) present in midline cells that is absent in the ventral
ectoderm and cannot be induced ectopically by sim. However,
MSR is not sufﬁcient to activate rho-365 expression in the absence
of Sim and MABP, since combined mutation of Motif-A and both
CMEs abolishes expression.
Another observation from the rho-365 misexpression experi-
ments suggests that sim induces an additional transcription factor
(s) (Sim-Induced Regulator; SIR) required for rho expression.
Expression of the rho-365 variant with both CMEs mutated is still
expanded in prd-Gal4 UAS-sim embryos. Since this sim-dependent
expansion cannot be working through the ACGTG sequences, this
suggests that ectopic sim induces expression of an additional
factor(s) activating rho-365; alternatively, Sim:Tgo is able to bind
Motif-A in this context to expand expression. The SIR protein may
be acting in a feed-forward mechanism with Sim. Similar to MSR,
SIR is not sufﬁcient to active rho-365 expression in the absence of
Sim and MABP. In summary, multiple midline speciﬁcity factors
exist that drive midline lineage-speciﬁc transcription even for
individual enhancers like rho-365.
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